Achieving meaningful device surveillance: From reaction to proaction

JAMA

Volumn 304, Issue 18, 2010, Pages 2065-2066

  Rumsfeld, John S ^a,b   Peterson, Eric D ^c  

^a VA Eastern Colorado Health Care System   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATION; CARDIOVASCULAR SURGERY; DEVICE; EVALUATION; FOOD AND DRUG ADMINISTRATION; HEART CATHETERIZATION; HUMAN; NOTE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; SAFETY;

EID: 78149347329     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1648     Document Type: Note

References (11)

1. Tavris DR, Dey S, Albrecht-Gallauresi B, et al. Risk of local adverse events following cardiac catheterization by hemostasis device use - phase II. J Invasive Cardiol. 2005;17(12):644-650.
2. O'Shea JC, Kramer JM, Califf RM, Peterson ED. Identifying holes in the safety net. Am Heart J. 2004;147(6):977-984.
3. Public health effectiveness of the FDA 510(k) clearance process. Institute of Medicine Web site. http://iom.edu/Activities/PublicHealth/ 510KProcess.aspx. Accessed October 10, 2010.
4. Platt R, Wilson M, Chan KA, Benner JS, Marchibroda J, McClellan M. The new Sentinel Network - improving the evidence of medical-product safety. N Engl J Med. 2009;361(7):645-647.
5. Resnic FS, Gross TP, Marinac-Dabic D, et al. Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA. 2010;304(18):2019-2027.
6. Douglas PS, Brennan JM, Anstrom KJ, et al. Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. J Am Coll Cardiol. 2009;53(18):1629-1641.
7. Tsai TT, Maddox TM, Roe MT, et al; National Cardiovascular Data Registry. Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA. 2009;302(22):2458-2464.
8. Albert NM, Yancy CW, Liang L, et al. Use of aldosterone antagonists in heart failure. JAMA. 2009;302(15):1658-1665.
9. Peterson ED, Kaul P, Kaczmarek RG, et al; Society of Thoracic Surgeons. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol. 2003;42(9):1611-1616.
10. Go AS, Magid DJ, Wells B, et al. The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2008;1(2):138-147.
11. Box TL, McDonell M, Helfrich CD, Jesse RL, Fihn SD, Rumsfeld JS. Strategies from a nationwide health information technology implementation: the VA CART story. J Gen Intern Med. 2010;25(suppl 1):72-76.